Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method

B Koristkova, M Grundmann, H Brozmanova, I Perinova, K Safarcik

. 2010 ; 32 (5) : 586-593.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14050192

Grantová podpora
1A8655 MZ0 CEP - Centrální evidence projektů

INTRODUCTION: Area under the concentration-time curve (AUC) has been advocated as a better parameter to monitor cyclosporine A than trough concentrations. Up to now, more than 100 equations to estimate AUC using a limited sampling strategy have been published, but not all have been validated. MATERIAL AND METHODS: Eight equations for AUC0-12h and two for AUC0-8h were validated. Concentrations of cyclosporine A were analyzed by high-performance liquid chromatography (HPLC) and a specific radioimmunoassay (RIA) method. Forty male renal transplant patients were included in the study. Blood samples were taken predose and at 0.5, 1, 1.5, 2, 3, 5, 8, and 12 hours after the morning dose when the patient was in steady state. The percentage prediction error (%pe) was used for an assessment of the performance of the equations. Mean %pe less than + 15% and absolute %pe less than 30% in 95% of predictions were considered to be acceptable. Other possibilities such as %pe less than 25%, 20%, and 15% were also tested. RESULTS: Eight equations for AUC0-12h met the requirements using both assays, six in the HPLC set only and four in the RIA set only. The highest precision was obtained with AUC0-12h = 123.792 + 1.165*C1h + 3.021*C3h + 7.33*C8h proposed by de Mattos et al. The mean %pe was 1% + 8% (-16 to 19) for HPLC (values given as mean + standard deviation [range]) and -1 + 5 (-17 to 10) for RIA. Mean absolute %pe was 7 + 5 (0.0 to 19) for HPLC and 4 + 4 (0.0 to 17) for RIA. For clinical use, the most suitable equation was AUC0-12h = 363.078 + 8.77*C1h + 3.07*C3h proposed by Wacke et al, which produced the second lowest %pe and used two sampling points in the period of 1 to 3 hours after dose. The mean %pe was -7 + 10 (-25 to 25) for HPLC and 2.3 + 6 (-10 to 17) for RIA. Mean absolute %pe was 10 + 7 (0.4 to 25) for HPLC and 5 + 4 (0.0 to 17) for RIA. The equation: AUC0-8h = 55.37 + 2.89*C0h + 1.08*C1h0.9*C2h + 2.23*C3h proposed by Foradori et al met the criteria with 95% of prediction with absolute %pe less than 15% in the HPLC set and 10% in the RIA set. CONCLUSION: The validation of equations is of major importance for prediction precision, whereas the analytical method for limited sampling strategy proposals had no influence. Because of the wide interassay variability, it is also important to know which analytical method was used for AUC calculation when interpreting the results.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14050192
003      
CZ-PrNML
005      
20140331124415.0
007      
ta
008      
140327s2010 xxu f 000 0eng||
009      
AR
024    __
$a 10.1097/ftd.0b013e3181ed59fe $2 doi
035    __
$a (PubMed)20683391
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kořístková, Blanka $7 xx0263946 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic. blanka.koristkova@seznam.cz
245    10
$a Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method / $c B Koristkova, M Grundmann, H Brozmanova, I Perinova, K Safarcik
504    __
$a Literatura
520    9_
$a INTRODUCTION: Area under the concentration-time curve (AUC) has been advocated as a better parameter to monitor cyclosporine A than trough concentrations. Up to now, more than 100 equations to estimate AUC using a limited sampling strategy have been published, but not all have been validated. MATERIAL AND METHODS: Eight equations for AUC0-12h and two for AUC0-8h were validated. Concentrations of cyclosporine A were analyzed by high-performance liquid chromatography (HPLC) and a specific radioimmunoassay (RIA) method. Forty male renal transplant patients were included in the study. Blood samples were taken predose and at 0.5, 1, 1.5, 2, 3, 5, 8, and 12 hours after the morning dose when the patient was in steady state. The percentage prediction error (%pe) was used for an assessment of the performance of the equations. Mean %pe less than + 15% and absolute %pe less than 30% in 95% of predictions were considered to be acceptable. Other possibilities such as %pe less than 25%, 20%, and 15% were also tested. RESULTS: Eight equations for AUC0-12h met the requirements using both assays, six in the HPLC set only and four in the RIA set only. The highest precision was obtained with AUC0-12h = 123.792 + 1.165*C1h + 3.021*C3h + 7.33*C8h proposed by de Mattos et al. The mean %pe was 1% + 8% (-16 to 19) for HPLC (values given as mean + standard deviation [range]) and -1 + 5 (-17 to 10) for RIA. Mean absolute %pe was 7 + 5 (0.0 to 19) for HPLC and 4 + 4 (0.0 to 17) for RIA. For clinical use, the most suitable equation was AUC0-12h = 363.078 + 8.77*C1h + 3.07*C3h proposed by Wacke et al, which produced the second lowest %pe and used two sampling points in the period of 1 to 3 hours after dose. The mean %pe was -7 + 10 (-25 to 25) for HPLC and 2.3 + 6 (-10 to 17) for RIA. Mean absolute %pe was 10 + 7 (0.4 to 25) for HPLC and 5 + 4 (0.0 to 17) for RIA. The equation: AUC0-8h = 55.37 + 2.89*C0h + 1.08*C1h0.9*C2h + 2.23*C3h proposed by Foradori et al met the criteria with 95% of prediction with absolute %pe less than 15% in the HPLC set and 10% in the RIA set. CONCLUSION: The validation of equations is of major importance for prediction precision, whereas the analytical method for limited sampling strategy proposals had no influence. Because of the wide interassay variability, it is also important to know which analytical method was used for AUC calculation when interpreting the results.
590    __
$a bohemika - dle Pubmed
650    02
$a plocha pod křivkou $7 D019540
650    02
$a odběr vzorku krve $7 D001800
650    02
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    02
$a cyklosporin $x farmakokinetika $x krev $x terapeutické užití $7 D016572
650    02
$a monitorování léčiv $x metody $7 D016903
650    02
$a lidé $7 D006801
650    02
$a imunosupresiva $x farmakokinetika $x krev $x terapeutické užití $7 D007166
650    02
$a transplantace ledvin $7 D016030
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a radioimunoanalýza $7 D011863
650    02
$a časové faktory $7 D013997
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Grundmann, Milan, $d 1939- $7 nlk20010093222 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Brozmanová, Hana $7 xx0103852 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Peřinová, Ilona, $d 1975- $7 xx0094982 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Šafarčík, Kristian, $7 mzk2006363477 $u Nuclear Medicine Clinic, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic $d 1950-
773    0_
$t Therapeutic Drug Monitoring $g Roč. 32, č. 5 (2010), s. 586-593 $p Ther Drug Monit $x 0163-4356 $w MED00004503
773    0_
$p Ther Drug Monit $g 32(5):586-93, 2010 Oct
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140327113806 $b ABA008
991    __
$a 20140331124452 $b ABA008
999    __
$a ok $b bmc $g 1017335 $s 848766
BAS    __
$a 3
BMC    __
$a 2010 $b 32 $c 5 $d 586-593 $i 0163-4356 $m Therapeutic drug monitoring $x MED00004503 $n Ther Drug Monit
GRA    __
$a 1A8655 $p MZ0
LZP    __
$a 2014-03/ewbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...